Henry Schein earnings were $314.0M for the trailing 12 months ending Sep 28, 2024, with -27.9% growth year over year. The latest HSIC earnings report on Sep 28, 2024 announced Q3 2024 earnings of $99.0M, down 4.8% from last quarter. For the last reported fiscal year 2023 ending Dec 30, 2023, HSIC reported annual earnings of $416.0M, with -22.7% growth. The next HSIC earnings date is Feb 25, 2025.
HSIC past earnings growth
How has HSIC's earnings growth performed historically?
On HSIC's earnings call on Invalid Date, Henry Schein (NASDAQ: HSIC) reported Q3 2024 earnings per share (EPS) of $0.79, up 25.47% year over year. Total HSIC earnings for the quarter were $99.00 million. In the same quarter last year, Henry Schein's earnings per share (EPS) was $1.06.
The next HSIC earnings date is Invalid Date. Add HSIC to your watchlist to be reminded of Henry Schein's next earnings date.
What was HSIC's earnings growth in the past year?
As of Henry Schein's earnings date in Invalid Date, Henry Schein's earnings has grown -27.86% year over year. This is 35.33 percentage points lower than the US Medical Distribution industry earnings growth rate of 7.47%. HSIC earnings in the past year totalled $314.00 million.
Is Henry Schein profitable or losing money?
As of the last Henry Schein earnings report, Henry Schein is currently profitable. Henry Schein's net profit (also called net income) for the twelve months ending Sep 28, 2024 was $314.00 million, a 29.44% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.